Home Carboxes 114214-49-2
114214-49-2,MFCD08691407
Catalog No.:AA000AQ8

114214-49-2 | tert-Butyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$9.00   $6.00
- +
5g
97%
in stock  
$13.00   $9.00
- +
10g
97%
in stock  
$16.00   $11.00
- +
25g
97%
in stock  
$32.00   $22.00
- +
100g
97%
in stock  
$125.00   $87.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000AQ8
Chemical Name:
tert-Butyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate
CAS Number:
114214-49-2
Molecular Formula:
C9H15NO3
Molecular Weight:
185.2203
MDL Number:
MFCD08691407
SMILES:
O=C(N1CC2C(C1)O2)OC(C)(C)C
Properties
Properties
 
BP:
252.7°C at 760 mmHg  
Form:
Liquid  
Refractive Index:
1.4600 to 1.4640  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
224  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
2  
XLogP3:
0.6  

Upstream Synthesis Route

[1]Tetrahedron,2003,vol.59,#49,p.9729-9742

[1]Tetrahedron,2003,vol.59,#49,p.9729-9742

[1]Tetrahedron,2003,vol.59,#49,p.9729-9742

[1]Tetrahedron,2003,vol.59,#49,p.9729-9742

[2]Synlett,2002,#2,p.310-312

[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,#21,p.4770-4773

[2]Patent:WO2013/96744,2013,A1,.Locationinpatent:Page/Pagecolumn221

[3]Patent:US2007/37853,2007,A1,.Locationinpatent:Page/Pagecolumn23

[4]Tetrahedron,2003,vol.59,#49,p.9729-9742

[5]Patent:WO2006/71958,2006,A1,.Locationinpatent:Page/Pagecolumn116

[6]Patent:WO2006/71875,2006,A1,.Locationinpatent:Page/Pagecolumn66;77-78

[7]BioorganicandMedicinalChemistryLetters,2016,vol.26,#1,p.228-234

[8]BioorganicandMedicinalChemistryLetters,1998,vol.8,#3,p.221-226

[9]Patent:WO2005/32541,2005,A1,.Locationinpatent:Page/Pagecolumn56

[10]Patent:US2011/144179,2011,A1,.Locationinpatent:Page/Pagecolumn25

[11]SyntheticCommunications,1996,vol.26,#8,p.1499-1505

[12]Patent:US2015/141402,2015,A1,.Locationinpatent:Paragraph0683;0684

[13]JournalofMedicinalChemistry,2017,vol.60,#7,p.3002-3019

[14]Patent:WO2010/114971,2010,A1,.Locationinpatent:Page/Pagecolumn153

[15]Patent:WO2006/44454,2006,A1,.Locationinpatent:Page/Pagecolumn14

[16]OrganicandBiomolecularChemistry,2009,vol.7,#9,p.1921-1930

[17]Patent:WO2011/8110,2011,A1,.Locationinpatent:Page/Pagecolumn42

[18]Patent:WO2009/153554,2009,A1,.Locationinpatent:Page/Pagecolumn38

[19]Patent:US2005/182095,2005,A1,.Locationinpatent:Page/Pagecolumn70

[20]Patent:WO2006/70284,2006,A1,.Locationinpatent:Page/Pagecolumn36

[21]Patent:US2011/166121,2011,A1,.Locationinpatent:Page/Pagecolumn67

[22]Patent:EP1849781,2007,A1,.Locationinpatent:Page/Pagecolumn90-91

[23]ChemicalandPharmaceuticalBulletin,1993,vol.41,#1,p.132-138

[24]JournalofMedicinalChemistry,1997,vol.40,#2,p.226-235

[25]TetrahedronAsymmetry,2001,vol.12,#21,p.2989-2997

[26]TetrahedronAsymmetry,2001,vol.12,#21,p.2989-2997

[27]Patent:WO2007/87231,2007,A2,.Locationinpatent:Page/Pagecolumn39

[28]Patent:WO2008/42353,2008,A1,.Locationinpatent:Page/Pagecolumn18;19-20;33;35-36

[29]JournaloftheAmericanChemicalSociety,2008,vol.130,#12,p.3900-3914

[30]JournalofMedicinalChemistry,2009,vol.52,#3,p.779-797

[31]Patent:US2003/229226,2003,A1,.Locationinpatent:Page18

[32]Patent:US2006/247238,2006,A1,.Locationinpatent:Page/Pagecolumn36

[33]JournalofHeterocyclicChemistry,2010,vol.47,#6,p.1392-1397

[34]Patent:WO2011/28979,2011,A1,

[35]Patent:WO2011/160020,2011,A2,.Locationinpatent:Page/Pagecolumn116-117

[36]Patent:WO2012/97121,2012,A2,.Locationinpatent:Page/Pagecolumn12-13

[37]JournalofMedicinalChemistry,2013,vol.56,#11,p.4357-4373

[38]Patent:US2013/273037,2013,A1,

[39]Patent:WO2013/138210,2013,A1,

[40]CentralEuropeanJournalofChemistry,2014,vol.12,#1,p.25-32

[41]Patent:WO2014/202458,2014,A1,.Locationinpatent:Paragraph00491;00492

[42]BioorganicandMedicinalChemistryLetters,2015,vol.25,#22,p.5058-5063

[43]Patent:TW2017/8220,2017,A,.Locationinpatent:Page/Pagecolumn61;62

[44]Patent:US2017/190713,2017,A1,.Locationinpatent:Paragraph0378

[45]Patent:CN107540659,2018,A,.Locationinpatent:Paragraph0210

[46]Patent:US2010/29708,2010,A1,.Locationinpatent:Page/Pagecolumn16

[47]Patent:WO2008/42353,2008,A1,.Locationinpatent:Page/Pagecolumn18;19-20;33;35-36

[48]JournalofMedicinalChemistry,2018,vol.61,#21,p.9738-9755

Downstream Synthesis Route
98-91-9    114214-49-2   
trans-3-benzoylthio-4-hydroxy-N-boc-pyrrolidine 

[1]Jin,Yonghao;Ghaffari,MohammadA;Schwartz,MartinA[TetrahedronLetters,2002,vol.43,#41,p.7319-7321]

[2]CurrentPatentAssignee:STATEUNIVERSITYSYSTEMOFFLORIDA-WO2005/32541,2005,A1Locationinpatent:Page/Pagecolumn57

[3]Jin,Yonghao;Roycik,MarkD.;Bosco,DaleB.;Cao,Qiang;Constantino,ManuelH.;Schwartz,MartinA.;Sang,Qing-XiangAmy[JournalofMedicinalChemistry,2013,vol.56,#11,p.4357-4373]

[1]TetrahedronAsymmetry,2001,vol.12,p.2989-2997

[2]Patent:WO2009/153554,2009,A1

[1]Tsuzuki,Yasunori;Chiba,Katsumi;Mizuno,Kazuhiro;Tomita,Kyoji;Suzuki,Kenji[TetrahedronAsymmetry,2001,vol.12,#21,p.2989-2997]

[2]CurrentPatentAssignee:TABOMEDEXBIOSCIENCES-US2017/190713,2017,A1

[1]Patent:WO2010/114971,2010,A1.Locationinpatent:Page/Pagecolumn153

[2]BioorganicandMedicinalChemistryLetters,1998,vol.8,p.221-226

[3]Patent:WO2004/108661,2004,A1.Locationinpatent:Page/Pagecolumn48-49

[4]Patent:WO2005/28454,2005,A1.Locationinpatent:Page/Pagecolumn50-51

[5]Patent:WO2004/838,2003,A1.Locationinpatent:Page71

[6]Patent:US2011/166121,2011,A1.Locationinpatent:Page/Pagecolumn67-68

[7]Patent:EP3543227,2019,A1.Locationinpatent:Paragraph0412-0413

[1]Patent:WO2006/71958,2006,A1.Locationinpatent:Page/Pagecolumn108-109;118

[2]Patent:WO2006/71958,2006,A1.Locationinpatent:Page/Pagecolumn108;117-118

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:114214-49-2 Molecular Formula|114214-49-2 MDL|114214-49-2 SMILES|114214-49-2 tert-Butyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate